Increased PT Only: A Prolonged PT with a Normal PTT
Initiation of Coumadin therapy or a very low dose of Coumadin
Inadequate intake of foods rich in vitamin K, such as cauliflower, broccoli, chick peas, other leafy vegetables
A stimulus for disseminated intravascular coagulation (DIC)
Evidence of liver disease from clinical or laboratory parameters
Family history of bleeding that could be associated with factor VII deficiency
Suggested Additional Lab Testing
Get liver function tests to assess whether the patient has liver disease and decreased synthesis of coagulation factors from the liver
Get a D-dimer or FDP as an assessment of DIC
If the test is positive, follow up with platelet count and measurement of fibrinogen.
In patients with DIC, these can be decreased or show decreasing values in two consecutive specimens at least several hours apart.
If DIC, Coumadin therapy, and vitamin K deficiency have been ruled out, measure the factor VII level and assess the possibility of an isolated factor VII deficiency.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Next Article in LabMed
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Steps to Facilitate Rapid Reperfusion to Improve Poststroke Outcomes
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Cerebellar Stimulation May Help Improve Gait and Balance Recovery in Stroke
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Risk for Conversion of MS Varies With Different Therapies
- Breakdown of Blood-Brain Barrier May Drive Dementia
- FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
- First Generic Version of Sabril Tablets Gets FDA Approval
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes